Sleep and Fibromyalgia Symptoms
words by mary ann littell
esley A. Allen, PhD, associate professor, psychiatry, UMDNJ-Robert Wood Johnson Medical School, is currently conducting an investigator-initiated clinical trial assessing the efficacy of Lunesta (eszopiclone) in the treatment of fibromyalgia symptoms, including sleep problems, pain and fatigue. Given that eszopiclone has been demonstrated to improve sleep in other populations, the researcher hypothesized that Lunesta would enhance the sleep of patients with fibromyalgia.
She recently completed another trial assessing the efficacy of a cognitive-behavioral intervention on the symptoms and functioning of patients with somatization disorder. A first trial assessing the efficacy of a similar intervention was published in 2006. This second study was conducted to determine the effect of a more intensive treatment, including group and individual therapy. Some 75 to 85 percent of Allen's study subjects are women.